Mostrar el registro sencillo del ítem
dc.contributor.author | Zhang, Xiaoan | es_ES |
dc.contributor.author | Ryu, Soo Hyung | es_ES |
dc.contributor.author | Xu, Yanjuan | es_ES |
dc.contributor.author | Elbaz, Tamerl | es_ES |
dc.contributor.author | Zekri, Abdel-Rahman N. | es_ES |
dc.contributor.author | Abdelaziz, Ashraf Omar | es_ES |
dc.contributor.author | Abdel-Hamid, Mohamed | es_ES |
dc.contributor.author | Thiers, Valerie | es_ES |
dc.contributor.author | Elena Fito, Santiago Fco | es_ES |
dc.contributor.author | Fan, Xiaofeng | es_ES |
dc.contributor.author | Di Bisceglie, Adrian M. | es_ES |
dc.date.accessioned | 2016-10-31T12:59:44Z | |
dc.date.available | 2016-10-31T12:59:44Z | |
dc.date.issued | 2011-12 | |
dc.identifier.issn | 1386-6532 | |
dc.identifier.uri | http://hdl.handle.net/10251/73002 | |
dc.description.abstract | [EN] Background: Hepatitis C virus (HCV) infection is a well-documented etiological factor for hepatocellular carcinoma (HCC). As HCV shows remarkable genetic diversity, an interesting and important issue is whether such a high viral genetic diversity plays a role in the incidence of HCC. Prior data on this subject are conflicting. Objectives: Potential association between HCV genetic mutations or strain variability and HCC incidence has been examined through a comparative genetic analysis merely focused on a single HCV subtype (genotype 4a) in a single country (Egypt). Study design: The study focused on three HCV sequence datasets with explicit sampling dates and disease patterns. An overlapping HCV Core/E1 domain from three datasets was used as the target for comparative analysis through genetic and phylogenetic approaches. Results: Based on partial Core/E1 domain (387 bp), genetic and phylogenetic analysis did not identify any HCC-specific viral mutations and strains, respectively. Conclusions: The Core/E1 domain of HCV genotype 4a in Egypt does not contain HCC-specific mutations or strains. Additionally, sequence errors resulting from the polymerase chain reaction, together with a strong evolutionary pressure on HCV in patients with end-stage liver disease, have significant potential to bias data generation and interpretation. (C) 2011 Elsevier B.V. All rights reserved. | es_ES |
dc.description.sponsorship | This work was supported by NIH grants R01 DK80711 (Dr. Xiaofeng Fan), R21 AI076834 (Dr. Adrian M. Di Bisceglie) and USA and Egypt Science and Technology Joint Fund BIO6-002-004 (Dr. Adrian M. Di Bisceglie). | |
dc.language | Inglés | es_ES |
dc.publisher | Elsevier | es_ES |
dc.relation.ispartof | Journal of Clinical Virology | es_ES |
dc.rights | Reconocimiento - No comercial - Sin obra derivada (by-nc-nd) | es_ES |
dc.subject | Hepatitis C virus | es_ES |
dc.subject | Hepatocellular carcinoma | es_ES |
dc.subject | Cirrhosis | es_ES |
dc.subject | RT-PCR | es_ES |
dc.subject | Egypt | es_ES |
dc.title | The Core/E1 domain of Hepatitis C virus genotype 4a in Egypt does not contain viral mutations or strains specific for hepatocellular carcinoma | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.1016/j.jcv.2011.08.022 | |
dc.relation.projectID | info:eu-repo/grantAgreement/NIH//R01DK80711/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/NIH//R21AI076834/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/U.S. - Egypt Science and Technology Joint Fund//BIO6-002-004/ | es_ES |
dc.rights.accessRights | Abierto | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Instituto Universitario Mixto de Biología Molecular y Celular de Plantas - Institut Universitari Mixt de Biologia Molecular i Cel·lular de Plantes | es_ES |
dc.description.bibliographicCitation | Zhang, X.; Ryu, SH.; Xu, Y.; Elbaz, T.; Zekri, AN.; Abdelaziz, AO.; Abdel-Hamid, M.... (2011). The Core/E1 domain of Hepatitis C virus genotype 4a in Egypt does not contain viral mutations or strains specific for hepatocellular carcinoma. Journal of Clinical Virology. 52(4):333-338. https://doi.org/10.1016/j.jcv.2011.08.022 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1016/j.jcv.2011.08.022 | es_ES |
dc.description.upvformatpinicio | 333 | es_ES |
dc.description.upvformatpfin | 338 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 52 | es_ES |
dc.description.issue | 4 | es_ES |
dc.relation.senia | 218205 | es_ES |
dc.identifier.pmid | 21925935 | |
dc.identifier.pmcid | PMC3217131 | |
dc.contributor.funder | National Institutes of Health, EEUU | |
dc.contributor.funder | U.S. - Egypt Science and Technology Joint Fund |